Table 1.

Study inclusion and exclusion criteria

	Group of interest	Patient control group	Healthy control group
Step 1	134 ovarian Germ Cell Tumor or Sex Cord Stromal tumor survivors	67 ovarian Germ Cell Tumor or Sex Cord Stromal tumor survivors	67 healthy women
Step 2	90 ovarian Germ Cell Tumor or Sex Cord Stromal tumors survivors	45 ovarian Germ Cell Tumor or Sex Cord Stromal tumor survivors	Not applicablea
Inclusion criteria	≥ 18 years old	≥ 18 years old	≥ 18 years old
		Age-matched to group of interest (± 2 years)	Age-matched to group of interest (± 2 years)
	Patient treated with surgery and BEP chemotherapy (≥ 1 cycle)	Patient treated with surgery alone (with or without fertility sparing).
	Patient in remission ≥2 years after initial treatment	Patient in remission ≥2 years after initial treatment
	Recurrence authorized if remission more than 2 years after end of initial treatment	Recurrence authorized if remission more than 2 years after the end of initial treatment
	Patient with no other cancers (except basal cell skin carcinoma, breast cancer and cervical cancer)	Patient with no other cancers (except basal cell skin carcinoma, breast cancer and cervical cancer)	Women without cancer or serious chronic diseases
	Patient having signed consent to participate	Patient having signed consent to participate	Healthy women accepted to complete online self-reported questionnaires
Exclusion criteria	Pregnant or breastfeeding woman
	Psychiatric disorders
	Major subject to legal protection or unable to express consent

BEP Bleomycin, Etoposide and Cisplatinum

^a: Healthy control group participated only in step 1 of study (self-reported questionnaire)